These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20965960)

  • 21. [Young-onset multiple sclerosis].
    Silva A; Sá MJ
    Rev Neurol; 1999 Jun 1-15; 28(11):1036-40. PubMed ID: 10390767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Towards a reliable prognosis for multiple sclerosis].
    Heinzlef O; Roullet E
    Rev Prat; 1999 Nov; 49(17):1872-5. PubMed ID: 10598503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
    Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
    Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
    Masjuan J; Alvarez-Cermeño JC; García-Barragán N; Díaz-Sánchez M; Espiño M; Sádaba MC; González-Porqué P; Martínez San Millán J; Villar LM
    Neurology; 2006 Feb; 66(4):576-8. PubMed ID: 16505315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.
    Zipoli V; Goretti B; Hakiki B; Siracusa G; Sorbi S; Portaccio E; Amato MP
    Mult Scler; 2010 Jan; 16(1):62-7. PubMed ID: 19995837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
    Di Pauli F; Reindl M; Ehling R; Schautzer F; Gneiss C; Lutterotti A; O'Reilly E; Munger K; Deisenhammer F; Ascherio A; Berger T
    Mult Scler; 2008 Sep; 14(8):1026-30. PubMed ID: 18632775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.
    Horakova D; Zivadinov R; Weinstock-Guttman B; Havrdova E; Tamaño-Blanco M; Tyblova M; Hussein S; Bergsland N; Willis L; Krasensky J; Vaneckova M; Seidl Z; Lelkova P; Ramanathan M
    J Neuroimmunol; 2011 Jul; 236(1-2):76-80. PubMed ID: 21621859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CIS case studies.
    Tumani H; Sapunova-Mayer I; Süssmuth SD; Hirt V; Brettschneider J
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S7-10. PubMed ID: 20106350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
    Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; Nos C; Arévalo MJ; Negrotto L; Galán I; Vidal-Jordana A; Castilló J; Palavra F; Simon E; Mitjana R; Auger C; Sastre-Garriga J; Montalban X
    Brain; 2015 Jul; 138(Pt 7):1863-74. PubMed ID: 25902415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.
    Gajofatto A; Monaco S; Fiorini M; Zanusso G; Vedovello M; Rossi F; Turatti M; Benedetti MD
    Arch Neurol; 2010 Jun; 67(6):724-30. PubMed ID: 20558391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
    Eisele P; Szabo K; Griebe M; Wolf ME; Hennerici MG; Gass A
    Mult Scler; 2014 Sep; 20(10):1391-5. PubMed ID: 24323819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum elements and oxidative status in clinically isolated syndromes: imbalance and predictivity.
    Ristori G; Brescianini S; Pino A; Visconti A; Vittori D; Coarelli G; Cotichini R; Bocca B; Forte G; Pozzilli C; Pestalozza I; Stazi MA; Alimonti A; Salvetti M
    Neurology; 2011 Feb; 76(6):549-55. PubMed ID: 21300970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.
    J Neurol; 2010 Jul; 257(7):1188-91. PubMed ID: 20157721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
    Minneboo A; Barkhof F; Polman CH; Uitdehaag BM; Knol DL; Castelijns JA
    Arch Neurol; 2004 Feb; 61(2):217-21. PubMed ID: 14967769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.
    Filippi M; Rocca MA; Calabrese M; Sormani MP; Rinaldi F; Perini P; Comi G; Gallo P
    Neurology; 2010 Nov; 75(22):1988-94. PubMed ID: 21115953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
    Sbardella E; Greco A; Stromillo ML; Prosperini L; Puopolo M; Cefaro LA; Pantano P; De Stefano N; Minghetti L; Pozzilli C
    Mult Scler; 2013 Apr; 19(4):411-7. PubMed ID: 22917691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.